Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)-Reference-Cited by-同舟云学术

Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)

Published:2021-04-19 Issue:9 Volume:64 Page:5323-5344
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Hahn Michael G.¹^ORCID,Lampe Thomas¹,El Sheikh Sherif¹,Griebenow Nils¹,Woltering Elisabeth¹,Schlemmer Karl-Heinz¹,Dietz Lisa¹,Gerisch Michael¹,Wunder Frank¹,Becker-Pelster Eva-Maria¹,Mondritzki Thomas¹²,Tinel Hanna¹,Knorr Andreas¹,Kern Armin¹,Lang Dieter¹^ORCID,Hueser Joerg¹,Schomber Tibor¹,Benardeau Agnes¹,Eitner Frank¹³,Truebel Hubert¹²,Mittendorf Joachim¹,Kumar Vijay⁴,van den Akker Focco⁴^ORCID,Schaefer Martina⁵,Geiss Volker¹,Sandner Peter¹⁶,Stasch Johannes-Peter¹⁷

Affiliation:

1. Research and Development, Bayer AG, Pharmaceuticals, Aprather Weg 18a, 42113 Wuppertal, Germany

2. University of Witten/Herdecke, 58455 Witten, Germany

3. Division of Nephrology and Clinical Immunology, RWTH Aachen University, 52074 Aachen, Germany

4. Department of Biochemistry, Case Western Reserve University, 44106 Cleveland, Ohio, United States

5. Lead Discovery−Structural Biology, Nuvisan ICB GmbH, 13353 Berlin, Germany

6. Institute of Pharmacology, Hannover Medical School, 30625 Hannover, Germany

7. Institute of Pharmacy, University Halle-Wittenberg, 06120 Halle, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine